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Ryszard Tomasiuk1, Malgorzata Mikaszewska-Sokolewicz2, Stanislaw Szlufik3*, Piotr Rzepecki2 and Tomasz Lazowski2Table 1 Median serum levels of NT-proCNP, C-reactive




NT-proCNP* (pmol/L) 7.1 (3.7 to 18.1) 4.5 (2.3 to 7.2)
PCT (ng/ml) 16.2 (2.5 to 36.2) 11.2 (2.1 to 38.4)
CRP* (mg/L) 132.5 (77.6 to 180.8) 93.8 (50.1 to 162.4)
IL-6 (pg/mL) 8.6 (4.0 to 47.6) 12.9 (5.5 to 57.5)
IL-8 (pg/mL) 167.7 (34.9 to 446.4) 175.2 (50.2 to 518.7)
IL-10 (pg/mL) 21.0 (9.0 to 57.0) 28.4 (12.0 to 66.0)
IL-12 (pg/mL) 3.5 (2.4 to 4.7) 3.1 (2.0 to 4.8)
TNF-α (pg/mL) 4.5 (1.6 to 6.2) 4.7 (1.6 to 6.0)Findings
The mortality of patients with sepsis in ICUs has been
decreasing since 1991 [1]. Nevertheless, there are still con-
flicting data regarding potential biomarkers of mortality
rate among critically ill patients and sepsis development.
N-terminal pro C-type natriuretic peptide (NT-proCNP)
is one of the markers whose usefulness is still uncertain.
Some authors have shown the possible role of NT-proCNP
in the prognosis of critically patients with sepsis [2] and in
polytrauma patients without brain injury who developed
sepsis [3], but Gouel-Chéron and colleagues [4] showed no
correlation between the serum level of NT-proCNP and
development of sepsis.
Our study aimed to explore the serum level of NT-
proCNP and its potential triggers (TNF-α, IL-6, IL-8, IL-10,
IL-12) and to correlate them with serum levels of procalci-
tonin (PCT) and C-reactive protein (CRP) as reviewed by
Uzzan and colleagues [5].
Samples were obtained from 90 critically ill adult pa-
tients during the first day in the ICU. The patients were
divided in two groups: patients who died of sepsis in the
ICU (43 patients), and ICU survivors (47 individuals). All
patients were assessed with the use of Acute Physiology
and Chronic Health Evaluation II score. ELISA kits were
used for quantitative determination of human NT-proCNP.
Cytokines were measured with the Fluorokine® MAP
cytokine multiplex kit and the Luminex® 100 Platform.
Statistical evaluation included Mann–Whitney U test
and Spearman correlation coefficient.
The median serum level of NT-proCNP was signifi-
cantly higher in non-survivors than in survivors: 7.1
(interquartile range (IQR) 3.7 to 18.1) pmol/L versus 4.5
(IQR 2.3 to 7.2) pmol/L, P < 0.05. Likewise, serum CRP
levels were higher in non-survivors than in survivors:* Correspondence: stanislaw.szlufik@gmail.com
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2014132.5 (IQR 77.6 to 180.8) mg/L versus 93.8 (IQR 50.1 to
162.4 ) mg/L, P < 0.05. The differences in median PCT, IL-6,
IL-8, IL-10, IL-12 and TNF- α levels did not reach statistical
significance (Table 1).
Our study is in agreement with the studies by Koch and
colleagues [2] and Bahrami and colleagues [3], supporting
the possibly important role of NT-proCNP as a prognostic
biomarker in sepsis. Inflammatory cytokines (like IL-1 and
TNF-α) are known to trigger the release of CNP from
endothelial cells but, interestingly, this was not confirmed
in our study (median levels of IL-1, TNF-α, IL-6, and IL-10
were not statistically correlated with survival). In our study
PCT was not a good prognostic factor either (possibly due
to the small cohort of patients).
Determination of CRP and NT-proCNP can potentially
determine the risk of death. Outcome prediction based on
these biomarkers may have sound clinical implications.
This requires further study in larger patient populations.*P < 0.05. CRP, C-reactive protein; IL, interleukin; NT-proCNP, N-terminal pro
C-type natriuretic peptide; PCT, procalcitonin; TNF, tumor necrosis factor.
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